UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
UBS analyst Ryan Gravett initiates coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and announces Price Target of $24.
UBS analyst Ryan Gravett initiates coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and announces Price Target of $24.